Mirna-383-5p functions as an anti-oncogene in glioma through the Akt/mTOR signal pathway by targeting VEGFA

Author:

Liu Yan1,Wang Zhen1,Tang Zhi2,Fu Yao3,Wang Lei2

Affiliation:

1. University of South China

2. Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University

3. Yiyang Central Hospital

Abstract

Abstract Background Previously, we screened a series of differentially expressed miRNAs and mRNA in glioma though bioinformatics analyses which included miRNA-383-5p and vascular endothelial growth factor A(VEGFA). This work aims to investigate the effects of miRNA-383-5p on the proliferation, migration and apoptosis of glioma cells, and the regulatory mechanism of miRNA-383-5p on the VEGFA/protein kinase B(Akt)/mechanistic target of rapamycin(mTOR) pathway. Methods Cells of U87 and U251 were collected. The expression of miRNA-383-5p was detected by real-time fluorescence quantitative PCR. Akt, mTOR VEGFA and its receptor VEGFR protein expression levels in glioma cells were detected with western blotting. The relationship between miRNA-383-5p and VEGFA was verified by dual-luciferase reporter gene assay. CCK-8, Transwell and flow cytometry assays were used to detect cell proliferation, invasion and apoptosis, respectively. Results Our results indicated that overexpression of miRNA-383-5p inhibited cell proliferation, migration, and invasion and promoted apoptosis in glioma cell lines. VEGFA was identified as a target of miRNA-383-5p, and overexpression of miRNA-383-5p significantly suppressed the levels of VEGFA and Akt/mTOR signaling pathway. Overexpression of VEGFA can reverse the inhibitory effect of miRNA-383-5p and reactivate the Akt/mTOR signaling pathway. Conclution Our results suggest that miRNA-383-5p inhibits the proliferation and migration of glioma cells by regulating the VEGFA/akt/mTOR pathway.

Publisher

Research Square Platform LLC

Reference29 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018

2. Management of glioblastoma: State of the art and future directions;Tan AC;CA Cancer J Clin,2020

3. Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1;Wang L;Journal of translational medicine,2021

4. miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L;Yu Z;Brain research bulletin,2021

5. miR-138-5p Inhibits the Growth and Invasion of Glioma Cells by Regulating WEE1;Gong J

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3